Literature DB >> 16123503

Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study.

Sara Giunti1, Graziella Bruno, Massimo Veglio, Gabriella Gruden, David J Webb, Shona Livingstone, Nish Chaturvedi, John H Fuller, Paolo Cavallo Perin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16123503     DOI： 10.2337/diacare.28.9.2255

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

1.  Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.

Authors:  Rachel G Miller; Tina Costacou; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2009-10-28       Impact factor: 3.291

Review 2.  Cardiovascular risk in double diabetes mellitus--when two worlds collide.

Authors:  Stephen J Cleland
Journal:  Nat Rev Endocrinol       Date:  2012-04-10       Impact factor: 43.330

3.  Relation between carotid intima-media thickness and left ventricular mass in type 1 diabetes mellitus (from the Epidemiology of Diabetes Interventions and Complications [EDIC] Study).

Authors:  Harjit Chahal; Jye-Yu C Backlund; Patricia A Cleary; John M Lachin; Joseph F Polak; Joao A C Lima; David A Bluemke
Journal:  Am J Cardiol       Date:  2012-08-09       Impact factor: 2.778

4.  Exercise Training Attenuates the Development of Cardiac Autonomic Dysfunction in Diabetic Rats.

Authors:  Ioannis Nakos; Nikolaos P E Kadoglou; Paraskevi Gkeka; Alexandros T Tzallas; Nikolaos Giannakeas; Dimitrios G Tsalikakis; Michalis Katsimpoulas; Georgios Mantziaras; Nikolaos Kostomitsopoulos; Christos D Liapis; John Kakisis
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

5.  NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α.

Authors:  Gabriella Gruden; Federica Barutta; Nish Chaturvedi; Casper Schalkwijk; Coen D Stehouwer; Silvia Pinach; Maria Manzo; Maria Loiacono; Marinella Tricarico; Giulio Mengozzi; Daniel R Witte; John H Fuller; Paolo Cavallo Perin; Graziella Bruno
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

Review 6.  The ECG vertigo in diabetes and cardiac autonomic neuropathy.

Authors:  Christina Voulgari; Nicholas Tentolouris; Christodoulos Stefanadis
Journal:  Exp Diabetes Res       Date:  2011-05-29

7.  N-Acetyl Cysteine, Selenium, and Ascorbic Acid Rescue Diabetic Cardiac Hypertrophy via Mitochondrial-Associated Redox Regulators.

Authors:  Iram Mushtaq; Zainab Bashir; Mehvish Sarwar; Maria Arshad; Ayesha Ishtiaq; Wajiha Khan; Uzma Khan; Sobia Tabassum; Tahir Ali; Tahzeeb Fatima; Hadi Valadi; Muhammad Nawaz; Iram Murtaza
Journal:  Molecules       Date:  2021-11-30       Impact factor: 4.411

8.  Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.

Authors:  Saul M Genuth; Jye-Yu C Backlund; Margaret Bayless; David A Bluemke; Patricia A Cleary; Jill Crandall; John M Lachin; Joao A C Lima; Culian Miao; Evrim B Turkbey
Journal:  Diabetes       Date:  2013-03-21       Impact factor: 9.461

9.  Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.

Authors:  J J K Lutale; H Thordarson; Z Gulam-Abbas; K Vetvik; E Gerdts
Journal:  Cardiovasc J Afr       Date:  2008 Jan-Feb       Impact factor: 1.167
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.